ArcticZymes Technologies ASA (OSL: AZT)

Market Cap	969.33M
Revenue (ttm)	117.80M
Net Income (ttm)	14.62M
Shares Out	51.07M
EPS (ttm)	0.28
PE Ratio	68.05
Forward PE	37.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	169,232
Open	19.42
Previous Close	19.70
Day's Range	18.72 - 19.44
52-Week Range	18.72 - 43.20
Beta	0.98
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during man...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 61
• Stock Exchange: Oslo Børs
• Ticker Symbol: AZT

Financial Performance

In 2023, AZT's revenue was 119.65 million, a decrease of -13.09% compared to the previous year's 137.67 million. Earnings were 19.43 million, a decrease of -40.89%.